925 search results for “covid-19 vaccine” in the Public website
-
Global, Regional and Local Politics of Institutional Responses to COVID-19 - Implications for Women and Children
The shift from response to recovery is now noticeable as the world moves past the paralyzing effects of the COVID-19 pandemic. This book explores responses to the pandemic by international, regional, and local institutions, multilateral action, and crisis prevention efforts at different levels of governance,…
-
ESOF session on vaccines: ‘Infectious diseases know no borders’
How can Europe lead the way in vaccine development that is fast and for all? To answer this pressing question, Professor of Vaccinology Meta Roestenberg is holding a panel session on 14 July at the EuroScience Open Forum in Leiden.
-
against time: Helping the Netherlands secure almost 20 million Pfizer vaccines
The whole world is waiting anxiously for sufficient supplies of coronavirus vaccines. As Launch Navigator at Pfizer, alumnus Dennis de Mik must help ensure that the Netherlands receives 19.8 million doses of the Pfizer/BioNTech vaccine. How is he going about this and how has his Bio-Pharmaceutical Sciences…
-
Tiny, pain-free vaccinations: microneedles and nanoparticles
If it’s up to PhD student Guangsheng Du, patients don’t need to worry about big needles anymore. At the Leiden Academic Center for Drug Research (LACDR), he studied the use of microneedles and nanoparticles as a new vaccination system. ‘I want to create a more patient-friendly delivery method.’ He defends…
-
Johan Kuiper: vaccin tegen aderverkalking
Ontwikkelen van een vaccin tegen aderverkalking
-
Developing a vaccine against arteriosclerosis
Cardiovascular diseases are the leading cause of death across the world. Professor Johan Kuiper of Leiden University carries out research to develop a vaccine for arteriosclerosis, which is the main cause of cardiovascular diseases. With the aid of a European research grant of six million euros he is…
-
Political Economy of Vaccine Diplomacy: Explaining Varying Strategies of China, India, and Russia’s COVID-19 Vaccine Diplomacy
Lecture, Lunch Research Seminar
-
Terrorism Experts’ Predictions Regarding the Effects of the COVID-19 Pandemic on the Activities of Violent Non-State Actors
In this article, Yannick Veilleux-Lepage and Tommy van Steen, assistant professors at the Institute of Security and Global Affairs, discuss the degree of consensus within the field of terrorism studies regarding the impact of the COVID-19 pandemic on the activities of violent non-state actors.
-
Linking crises: Connections between climate change and COVID-19 during American, Canadian, Dutch, and Lithuanian national elections (2020-2021)
The aim of this research is to understand the linking of crises for the combination of climate change and the COVID-19 pandemic.
-
discourses on political authorities in high-trust countries during the COVID-19 pandemic
This study looks at population response to government containment strategies during initial stages of the COVID-19 pandemic in four high-trust Northern European countries–Denmark, Germany, the Netherlands, and Sweden–with special emphasis on expressions of governmental trust.
-
Cancer vaccine packaged in minute particles
Leiden researchers have carried out successful tests using a new method of packaging a cancer vaccine in nano-particles. The new vaccine has induced a strong immune reaction in mice. The researchers believe that this method can make an important contribution to the treatment of cancer. Their findings…
- Dossiers
-
When will there be a coronavirus vaccine?
The genetic code of the new coronavirus has been found: it is closely related to the SARS virus from 2003. Professor of Molecular Virology, Eric Snijder, has been researching coronaviruses for years. We asked him a few questions about the outbreak. ‘It’s still unclear whether this new virus is more…
-
Biotherapeutic Delivery
The research of the Biotherapeutic Delivery group led by Joachim Van Guyse focuses on developing novel polymer-based formulations for therapeutic nucleic acid and protein delivery. The research revolves around developing structure-activity relationships between the chemical structure of polymers, the…
-
Mirjam Sombroek asked by Minister of Health for urgent advice on vaccination of children
Associate Professor Mirjam Sombroek has been asked for advice on account of her expertise in the area of health law and children’s rights.
-
Total Synthesis of Alginate and Zwitterionic Sp1 Oligosaccharides
The work in this thesis has been focused on two subjects. The first is the assembly of alginate oligosaccharides and the generation of building blocks for the enzymatic synthesis of alginate, and the second is the total synthesis of large fragments of the zwitterionic SP1 polysaccharide.
-
Testing of a malaria vaccine gets the green light
Researchers at Leiden University Medical Center (LUMC) and Radboud university medical center have been given the green light to deliberately infect volunteers with malaria in order to test a highly promising vaccine on them.
-
New insights for improved pertussis vaccines - Press release -
Researchers in Bilthoven, The Netherlands, have recently unraveled the defense against whooping cough bacteria in unprecedented detail. The outcome of the project, conducted at Intravacc (Institute for Translational Vaccinology) in Bilthoven, provides opportunities for a new approach in the development…
-
Can businesses and employers demand proof of vaccination?
Can bars, gyms and travel providers refuse customers who have no proof of vaccination? And can an employer dismiss employees who are not vaccinated? Reports in the Dutch media about travel organisations and a dance instructor who are refusing customers who have not yet been fully vaccinated have sparked…
-
Therapeutic vaccine boosts survival rate in cervical cancer patients
A therapeutic vaccine against HPV-16 (type 16 human papillomavirus) improves the survival rate in cervical cancer patients. A new study by ISA Pharmaceuticals B.V. (a Leiden-based biotechnology company) and the Leiden University Medical Center (LUMC) shows that this vaccine produces a more robust response…
-
Tom Barkhuysen on possible introduction of compulsory vaccination
More and more countries have decided to introduce compulsory vaccination. According to various experts, compulsory vaccination, under certain conditions, could help the situation in the Netherlands.
-
First clinical trial with genetically modified malaria vaccine completed
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.
-
COVID-19 Library update
Dear library friends,
-
Can non-vaccinated persons soon be barred?
Private businesses will probably soon refuse access to non-vaccinated persons in the near future. But this is more difficult when it comes to public amenities. Aart Hendriks, Professor of Health Law at Leiden Law School, contributed to an article in Dutch newspaper NRC saying that he anticipates that…
-
International Espionage on the Lookout for the Corona Vaccine
With the ongoing development of a corona vaccine, intelligence services worldwide are being deployed for international espionage. Willemijn Aerdts, Lecturer Intelligence Services at the Institute of Security and Global Affairs, was interviewed by the Dutch BNR News Radio. Aerdts is an expert in the…
-
Towards controlled microneedle-mediated intradermal immunization
Traditionally, vaccines are administered intramuscularly using conventional hypodermic needles, which cause pain and distress. Microneedles are very short needles (smaller than 1 mm) that are practically invisible to the naked eye.
-
‘12-year-olds capable of deciding about vaccination with assistance’
Children aged between 12 and 17 years can decide themselves whether they want to be vaccinated or not. Experts say that children are capable of taking a well-considered decision.
-
Research
Biotherapeutics or biologics, such as proteins, peptides, and nucleic acids, comprise an increasing share of the pharmaceutical market, whilst offering new therapies for difficult-to-treat diseases. Most notable is their contribution to the vaccination efforts during the COVID-19 pandemic. In most cases,…
-
Systems vaccinology: molecular signatures of immunity to Bordetella pertussis
Promotor: G.F.A. Kersten, W. Jiskoot, Co-promotor: B. Metz
-
What Accounts for the Variety of National Policy Responses to the COVID-19 Pandemic in Europe?
What Accounts for the Variety of National Policy Responses to the COVID-19 Pandemic in Europe?
-
Five times more Covid vaccines from a vial with skin injection
Not ten but fifty Covid vaccines from one vial. This is possible if the vaccination is delivered into the skin rather than the muscle, research by internist and infectious disease specialist Anna Roukens from the LUMC has shown. EenVandaag reported on this important discovery, which could have huge…
-
Predicting and preventing serious COVID-19 symptoms
Scientists in Leiden are looking for signals in blood samples to predict whether patients will develop serious COVID-19 symptoms or not. Based on that knowledge, they will be able to propose targeted therapies to prevent serious symptoms. They hope to come up with the first results within the week.
-
Jeroen Codee
Science
jcodee@chem.leidenuniv.nl | +31 71 527 5037
-
Aart Hendriks: Compulsory vaccination is in the interest of public health
Yesterday, the House of Representatives in the Netherlands rejected a motion that would completely rule out an obligation to get vaccinated. Compulsory vaccination in the Netherlands can be considered if public health is at stake. Professor of Health Law Aart Hendriks of Leiden University discussed…
-
Which antibodies are most effective against coronavirus?
Researchers Indu Khatri, Frank Staal and Jacques van Dongen from Leiden University Medical Center (LUMC) have published a perspective article in Frontiers in Immunology about coronavirus and its characteristic ‘spike protein.’ They predict which antibodies would provide the best protection against the…
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Surge in bankruptcies inevitable despite Covid-19 relief measures
The extension of the Dutch government’s Covid-19 relief measures for businesses has ensured that in the last six months of 2020 the number of bankruptcies was at an all-time low. However, according to the Bijzonder Beheer Barometer (special risk management barometer) an initiative of PwC and the Department…
-
Leiden Anthropologists Reflect on the COVID-19 Pandemic
The coronavirus outbreak raises fundamental questions about the politics and narratives of crisis, as well as about our “ordinary” everyday lives and sociality. Irene Moretti and Annemarie Samuels introduce a collection of blogposts of Leiden Anthropologists reflecting on the pandemic and offer a set…
-
LUMC involved in development of novel drugs to treat and prevent SARS-CoV-2 and other coronaviruses
The Department of Medical Microbiology at Leiden University Medical Center (LUMC) is researching antiviral drugs that could treat and prevent SARS-CoV-2 in various projects. One part of the PanCoroNed project is being led by Martijn van Hemert and involves lab tests into the antiviral effect of molecules…
-
Bacterial glycomimetics: synthesis and applications
This work has described synthetic strategies towards well-defined structures resembling capsular polysaccharide (CPS) fragments, CPS mimics, teichoic acid (TA) fragments as well as a third-generation ring-closing tandem metathesis (RCM) linker to better exploit the potential of automated synthesis.
-
UMCs join forces to increase pandemic preparedness
Four university medical centres, including the LUMC, are joining forces to increase pandemic preparedness in the Netherlands.
-
Leiden University and LUMC strengthen ties with Janssen pharmaceutical company
Leiden University, the LUMC and Janssen have signed a partnership agreement stating that they will collaborate in different areas, including infectious disease prevention, clinical tests, drug production and e-health. By joining forces, the three partners will be able to provide better, more innovative…
-
Staying Ahead of the Virus
In STAYAHEAD data-intensive approaches are being developed to ”decode the human immunome” with a focus on a global vaccine strategy. They have developed a rapid mass spectrometric test to analyse in real-time large numbers of variants of SARS-CoV-2 and the host immune response, and use these data to…
-
Predicting and preventing Covid-19: 1 million euros for corona research
How is it that some covid-19 patients are affected much worse than others? Can we predict beforehand which of them will develop critical symptoms Professor Thomas Hankemeier, together with a diverse consortium of universities, academic hospitals and industrial partners, is looking for the answers to…
-
COVID-19 Research and Education at Leiden Academic Centre for Drug Research
Since the start of the Corona crisis, several COVID-19 related research and teaching projects were started at LACDR. The computational and teaching activities started right away, as well as a large-scale metabolomics screening program by Thomas Hankemeier’s group. Other experimental activities are still…
-
Beryl ter Haar "Special Issue: Covid-19 and Labour Law, A Global Review"
Beryl ter Haar co-editor of the Italian Labour Law e-Journal's
-
Voyage to Corona. An artistic insight on COVID-19 by Federico de Musso
In February Cultural Anthropologist Federico de Musso went to Northern Italy to visit his family. He was there for three days when COVID-19 cases started to skyrocket. Back in the Netherlands, he put himself into preventive quarantine, just in case he had contracted the disease. It turned out he did…
-
Rijpma at ICMPD Webinar “Protecting the Right to Protection in times of COVID-19”
On 22 June the International Centre for Migration Policy Development (ICMPD) organised a webinar on the challenges that have arisen for asylum seekers and refugees worldwide as a result of the COVID-19 crisis.
-
Development of synthetic procedures towards immunostimulating carbohydrates
Promotor: G.A. van der Marel, Co-Promotor: J.D.C. Codée
-
AI versus corona
It’s all hands on deck at the moment to resolve the COVID-19 crisis. Researchers from various disciplines are helping where they can, also from the field of artificial intelligence (AI). AI offers great opportunities both at the frontline of the crisis and in its expected aftermath. Leiden professor…